Detalhe da pesquisa
1.
Uric acid and sodium-glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction: the EMPEROR-reduced trial.
Eur Heart J
; 43(36): 3435-3446, 2022 09 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35788657